/Companies

Rappta

4 known investors

Find your way into Rappta

Sign up to see every warm intro you have to Rappta

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Rappta team. We find them
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Rappta Therapeutics develops small molecule compounds that reactivate protein phosphatase 2A (PP2A) to treat cancer by restoring the enzyme's tumor suppressor function. The company targets the underlying mechanism of protein hyperphosphorylation that drives cancer progression.

Investors · 4

Also in the syndicate · 1

Novo Seedslead

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Frequently asked questions

What does Rappta do?
Rappta Therapeutics develops small molecule compounds that reactivate protein phosphatase 2A (PP2A) to treat cancer by restoring the enzyme's tumor suppressor function. The company targets the underlying mechanism of protein hyperphosphorylation that drives cancer progression.
Who are Rappta's investors?
Rappta's investors include Advent Life Sciences, Novartis Venture Fund, Novo Holdings.